Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
4 Articles
4 Articles
Biosidus expands its biological product manufacturing capacity and strengthens its global supply capacity of agalsidase beta
The AI Journal
Business News This WeekBiosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
BUENOS AIRES, Argentina, Aug. 26, 2026 /PRNewswire/ — Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing of biosimilar medicines, announced that its new bioreactor plant is now operational, increasing the company’s biologics production capacity and reinforcing its ability to support potential international demand. The expansion strengthens Biosidus’ industrial platform at …
Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta - Business News Week
BUENOS AIRES, Argentina, Aug. 26, 2026 /PRNewswire/ — Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing of biosimilar medicines, announced that its new bioreactor plant is now operational, increasing the company’s biologics production capacity and reinforcing its ability to support potential international demand. The expansion strengthens Biosidus’ […] The post Biosidus ex…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
